GCG and diabetes mellitus: Given the diminished effect of native incretins in T2D (34), which primarily engage the Gαs/cAMP pathway, it seems reasonable to propose that preferential engagement of alternative pathways would be an effective strategy to leverage incretin receptor activity to treat people with diabetes.